Metropolis Healthcare logs highest-ever revenue in FY22; registers 17% yoy growth in PAT

25 May 2022 , 03:43 PM

Metropolis Healthcare Ltd., one of the leading diagnostic service providers, has announced its audited consolidated financial results today for the quarter and financial year ended March 31, 2022.

The company has logged revenue of Rs1228.30 crore in FY22, up by 23% yoy against its previous close of Rs998 crore in FY21.

Company’s PAT during the financial year ended March 31, 2022, was reported at Rs214.70 crore as compared to Rs183.30 crore in the previous financial year, up by 17% yoy.

EBITDA for FY22 stood at Rs361.60 crore, registering a growth of 20% yoy against Rs301.30 crore in the previous financial year.

EBITDA margin declined to 29.40% in FY22 against 30.20% in FY21. PAT margin for FY22 was 17.5% as compared to 18.40% in FY21.

The company further stated that Patient visits increased by 37% on yoy basis to 13.4 million in FY22, No. of tests increased by 35% on yoy basis to 25.7 million in FY22, and Non-Covid Home Visits revenue increased by 23% yoy Rs98 crore.

Metropolis Healthcare ended at Rs1,575.90 down by Rs112.6 or 6.67% from its previous closing of Rs1,688.50 on the BSE. The scrip touched a high and low of Rs1,784.60 and Rs1,565.45 respectively in today’s trade.